StockNews.com initiated coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a report issued on Friday. The firm issued a hold rating on the stock.
Brooklyn ImmunoTherapeutics Trading Down 6.0 %
NYSE BTX opened at $0.42 on Friday. Brooklyn ImmunoTherapeutics has a 1-year low of $0.17 and a 1-year high of $10.10. The firm’s fifty day simple moving average is $0.44 and its 200-day simple moving average is $1.11. The company has a market capitalization of $24.84 million, a PE ratio of -0.19 and a beta of 4.61.
Brooklyn ImmunoTherapeutics Company Profile
See Also
- Five stocks we like better than Brooklyn ImmunoTherapeutics
- Insider Buying Explained: What Investors Need to Know
- Earn High Dividends With 2 Top REITs Set to Perform in 2025
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Oilfield Leader SLB: An AI Name You Need to Know
- 3 Tickers Leading a Meme Stock Revival
- Top ETFs That Beat the Market in 2024 and Could Do It Again
Receive News & Ratings for Brooklyn ImmunoTherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Brooklyn ImmunoTherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
